Study Validates RainDance's Microdroplet PCR Technology for Targeted Resequencing | GenomeWeb

NEW YORK (GenomeWeb News) – A study published in the November issue of Nature Biotechnology has found that RainDance Technologies' microdroplet-based PCR method is well suited for large-scale targeted resequencing studies, and more scalable than the "gold standard" of traditional PCR for that application.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.